(Q51370903)

4 April 2018

title

Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice. (English)

1 reference

4 April 2018

author name string

Kuzmin AV

1

1 reference

4 April 2018

Gerrits MA

2

1 reference

4 April 2018

Zvartau EE

3

1 reference

4 April 2018

van Ree JM

4

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 December 2000

1 reference

4 April 2018

European Neuropsychopharmacology

published in

1 reference

4 April 2018

volume

10

1 reference

4 April 2018

issue

6

1 reference

4 April 2018

page(s)

447-454

1 reference

4 April 2018

Opioidergic modulation of cocaine conditioned place preferences.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Buprenorphine abuse: report from India

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Combined effects of buprenorphine and a nondrug alternative reinforcer on i.v. cocaine self-administration in rats maintained under FR schedules.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Kappa opioid inhibition of morphine and cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Discriminative stimulus effects of buprenorphine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Role of opioid antagonists in treating intravenous cocaine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Modulation of cocaine intravenous self-administration in drug-naive animals by dihydropyridine Ca2+ channel modulators.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Opioid agonist and antagonist behavioural effects of buprenorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Buprenorphine-induced alterations of cocaine's reinforcing effects in rhesus monkey: a dose-response analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Buprenorphine self-administration by rhesus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Buprenorphine suppresses cocaine self-administration by rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Naltrexone-buprenorphine interactions: effects on cocaine self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

The effects of nalbuphine and butorphanol treatment on cocaine and food self-administration by rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Buprenorphine abuse among opiate addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Simple methodology of assessment of analgesics' addictive potential in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Discrimination of butorphanol and nalbuphine in opioid-dependent humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Chronic pretreatment with naltrexone facilitates acquisition of intravenous cocaine self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Dissociation of buprenorphine-induced locomotor sensitization and conditioned place preference in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

1 reference

7 January 2021

Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Substitution and primary dependence studies in animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900117-6

7 January 2021

10.1016/S0924-977X(00)00117-6

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018